伏立康唑对造血细胞移植后非黑色素瘤皮肤癌风险的影响
该回顾性队列研究纳入1220例异基因和1418例自体造血细胞移植患者,多因素分析显示伏立康唑使用增加异基因移植患者非黑色素瘤皮肤癌风险(HR 1.82,95%CI 1.13-2.91),尤其鳞状细胞癌(HR 2.25,95%CI 1.30-3.89),而自体移植患者未见风险增加。
要点
- 伏立康唑使用是异基因造血细胞移植后鳞状细胞癌的独立危险因素。
- 异基因移植患者使用伏立康唑需加强皮肤癌监测。
- 自体造血细胞移植患者使用伏立康唑未见非黑色素瘤皮肤癌风险增加。
核心结论
- 伏立康唑使用是异基因造血细胞移植人群鳞状细胞癌风险增加的独立因素。
研究设计与样本
- 回顾性队列研究,纳入1220例异基因造血细胞移植和1418例自体造血细胞移植患者,采用多因素分析评估伏立康唑暴露与非黑色素瘤皮肤癌风险。
主要发现
- 异基因移植患者中,伏立康唑使用增加非黑色素瘤皮肤癌风险(HR 1.82,95%CI 1.13-2.91),尤其鳞状细胞癌(HR 2.25,95%CI 1.30-3.89)。
- 自体移植患者中,伏立康唑使用未见非黑色素瘤皮肤癌风险增加。
临床怎么用
- 对异基因造血细胞移植后使用伏立康唑的患者,应关注皮肤癌筛查与随访。
局限性
- 本研究为回顾性研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Voriconazole has previously been associated with increased risk for cutaneous squamous cell carcinoma (SCC) in solid organ transplant recipients. Less is known about the risk in patients after hematopoietic cell transplantation (HCT). OBJECTIVE: We evaluated the effect of voriconazole on the risk for nonmelanoma skin cancer (NMSC), including SCC and basal cell carcionoma, among those who have undergone allogeneic and autologous HCT. METHODS: In all, 1220 individuals who had undergone allogeneic HCT and 1418 who had undergone autologous HCT were included in a retrospective cohort study. Multivariate analysis included voriconazole exposure and other known risk factors for NMSC. RESULTS: In multivariate analysis, voriconazole use increased the risk for NMSC (hazard ratio, 1.82; 95% confidence interval, 1.13-2.91) among those who had undergone allogeneic HCT, particularly for SCC (hazard ratio, 2.25; 95% confidence interval, 1.30-3.89). Voriconazole use did not appear to confer increased risk for NMSC among those who had undergone autologous HCT. LIMITATIONS: This is a retrospective study. CONCLUSION: Voriconazole use represents an independent factor that may contribute to increased risk specifically for SCC in the allogeneic HCT population.
引用
- Kuklinski LF, Li S, Karagas MR, et al. Effect of voriconazole on risk of nonmelanoma skin cancer after hematopoietic cell transplantation. J Am Acad Dermatol. 2017. PMID: 28780363. doi:10.1016/j.jaad.2017.06.032
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。